News

Fierce Pharma6h
With China approval, Lilly and Innovent's mazdutide breaks into new class for GLP-1 obesity drugs
In a breakthrough for incretin medicines, China’s National Medical Products Administration (NMPA) has approved Innovent’s ...
STAT4d
Eli Lilly drug preserves lean mass in patients losing weight on Wegovy
Some doctors are concerned that patients taking weight loss drugs like Wegovy may be losing too much lean mass. A combination ...
BioSpace3d
Lilly’s Antibody Protects Patients From Losing Muscle While Taking Novo’s Wegovy
Eli Lilly's bimagrumab led to weight loss that was due almost entirely to fat reduction when combined with semaglutide, ...
Fierce Pharma6h
After Novo and Lilly resolved GLP-1 shortages, where does the compounding industry stand? Experts weigh in
Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...
Lilly Drug Saves Muscle When Added to Wegovy Weight-Loss Shot
Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...
Novo Nordisk launches weight-loss drug Wegovy in India to compete with rival Lilly's Mounjaro
By Rishika Sadam and Kashish Tandon HYDERABAD (Reuters) -Danish drugmaker Novo Nordisk launched its blockbuster weight-loss ...
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
Eli Lilly to roll out diabetes medicine in prefilled pen
Eli Lilly will soon launch Mounjaro KwikPen in India. This follows regulatory approval for the diabetes and obesity drug. The ...
3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
Eli Lilly isn't a one-trick pony. The company's lineup of approved medicines features blockbusters like Verzenio, a cancer ...
India Today on MSN3d
Wegovy and Lilly's bimagrumab combo shows weight loss without muscle loss
A new study finds combining bimagrumab with Wegovy leads to significant fat loss without muscle loss. This breakthrough ...
Exclusive-New data show most US patients now stay on Wegovy, Zepbound after a year
By Chad Terhune LOS ANGELES (Reuters) -Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last ...